James R. Kasinger
General Counsel and Secretary at CRISPR Therapeutics · 10 reported transactions in 1 company · latest trade Oct 14, 2026
Their trades
Sold | Oct 14, 2026 | Oct 14, 2026 close $50.22 → Oct 29, 2026 close $54.26. S&P 500 +0.3% over the same days. | ||
Sold | Oct 6, 2026 | Oct 6, 2026 close $54.00 → Oct 29, 2026 close $54.26. S&P 500 −0.9% over the same days. | ||
Sold | Sep 22, 2026 | Sep 22, 2026 close $59.03 → Oct 29, 2026 close $54.26. S&P 500 −0.1% over the same days. | ||
Sold | Feb 19, 2026 | Feb 19, 2026 close $54.64 → Oct 29, 2026 close $54.26. S&P 500 +12.8% over the same days. | ||
Sold | Oct 14, 2025 | Oct 14, 2025 close $69.38 → Oct 29, 2026 close $54.26. S&P 500 +16.6% over the same days. |
$51.2K
Oct 14, 2026 close $50.22 → Oct 29, 2026 close $54.26. S&P 500 +0.3% over the same days.
$119.5K
Oct 6, 2026 close $54.00 → Oct 29, 2026 close $54.26. S&P 500 −0.9% over the same days.
$626.5K
Sep 22, 2026 close $59.03 → Oct 29, 2026 close $54.26. S&P 500 −0.1% over the same days.
$111K
Feb 19, 2026 close $54.64 → Oct 29, 2026 close $54.26. S&P 500 +12.8% over the same days.
$71.7K
Oct 14, 2025 close $69.38 → Oct 29, 2026 close $54.26. S&P 500 +16.6% over the same days.